2025
SJR Q2
JCR Q2 · 2,4
OA
154 matched articles
SCIE
Journal detail
Breast Journal
- Publisher
- John Wiley and Sons Inc
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1075122X15244741
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,649
- Quartile Q2
- H-Index 88
- Cites/doc 2,29
- Docs (3y) 103
- Cites (3y) 265
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,4
- 5Y JIF 1,9
- JCI 0,55
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Internal Medicine Q2
- Oncology Q3
- Surgery Q2
Areas
- Medicine
WoS categories
- Oncology | Obstetrics & Gynecology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,649 | 2,4 | 1,9 | 0,55 | Q3 | 88 |
| 2024 | Q2 | Q2 | 0,453 | 2 | 2,1 | 0,47 | Q3 | 85 |
| 2023 | Q2 | Q3 | 0,446 | 1,9 | 2,1 | 0,44 | Q3 | 85 |
| 2022 | Q2 | Q3 | 0,395 | 2,1 | 2,2 | 0,45 | Q3 | 85 |
| 2021 | Q2 | Q3 | 0,461 | 2,3 | 2,4 | 0,48 | Q3 | 85 |
| 2020 | Q2 | Q3 | 0,533 | 2,4 | 2,7 | 0,61 | Q3 | 85 |
| 2019 | Q2 | Q3 | 0,661 | 2 | 2,3 | 0,71 | Q2 | 85 |
| 2018 | — | Q2 | — | 2,4 | 2,4 | 0,84 | Q2 | — |
| 2017 | Q2 | Q2 | 0,809 | 2,4 | 2 | 0,8 | Q2 | 85 |
| 2016 | Q1 | Q2 | 0,923 | 2,3 | 2 | — | — | 85 |
| 2015 | Q1 | Q2 | 0,82 | 1,9 | 1,9 | — | — | 85 |
| 2014 | Q2 | Q3 | 0,773 | 1,4 | 1,6 | — | — | 85 |
| 2013 | Q2 | Q3 | 0,726 | 1,4 | 1,8 | — | — | 85 |
| 2012 | Q2 | Q2 | 0,727 | 1,8 | 1,9 | — | — | 85 |
| 2011 | Q1 | Q3 | 0,766 | 1,6 | 2,2 | — | — | 85 |
| 2010 | Q2 | Q3 | 0,528 | 1,4 | 2 | — | — | 85 |
| 2009 | — | Q3 | — | 1,6 | — | — | — | — |
| 2008 | — | Q2 | — | 2,1 | — | — | — | — |
| 2007 | — | Q2 | — | 1,7 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | Q3 | 58/143 |
| 2025 | ONCOLOGY | SCIE | Q3 | Q3 | 214/333 |
| 2024 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | Q3 | 59/141 |
| 2024 | ONCOLOGY | SCIE | Q3 | Q3 | 233/328 |
| 2023 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | Q3 | 69/136 |
| 2023 | ONCOLOGY | SCIE | Q3 | Q3 | 234/322 |
| 2022 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | Q3 | 57/85 |
| 2022 | ONCOLOGY | SCIE | Q4 | Q3 | 207/241 |
| 2021 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | Q3 | 63/85 |
| 2021 | ONCOLOGY | SCIE | Q4 | Q3 | 215/245 |
| 2020 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | Q3 | 50/83 |
| 2020 | ONCOLOGY | SCIE | Q4 | Q3 | 211/242 |
| 2019 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | Q2 | 48/82 |
| 2019 | ONCOLOGY | SCIE | Q4 | Q2 | 204/244 |
| 2018 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | Q2 | 29/83 |
| 2018 | ONCOLOGY | SCIE | Q3 | Q2 | 155/230 |
| 2017 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | Q2 | 30/82 |
| 2017 | ONCOLOGY | SCIE | Q3 | Q2 | 154/223 |
| 2016 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | — | 33/80 |
| 2016 | ONCOLOGY | SCIE | Q3 | — | 145/217 |
| 2015 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | — | 37/80 |
| 2015 | ONCOLOGY | SCIE | Q3 | — | 158/213 |
| 2014 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | — | 54/79 |
| 2014 | ONCOLOGY | SCIE | Q4 | — | 178/211 |
| 2013 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | — | 53/78 |
| 2013 | ONCOLOGY | SCIE | Q4 | — | 165/203 |
| 2012 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | — | 37/78 |
| 2012 | ONCOLOGY | SCIE | Q3 | — | 138/197 |
| 2011 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | — | 41/79 |
| 2011 | ONCOLOGY | SCIE | Q3 | — | 141/196 |
| 2010 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | — | 47/77 |
| 2010 | ONCOLOGY | SCIE | Q4 | — | 144/185 |
| 2009 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | — | 37/70 |
| 2009 | ONCOLOGY | SCIE | Q3 | — | 116/166 |
| 2008 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | — | 24/61 |
| 2008 | ONCOLOGY | SCIE | Q3 | — | 98/143 |
| 2007 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | — | 24/60 |
| 2007 | ONCOLOGY | SCIE | Q3 | — | 91/132 |